Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-016854

IMMUNOMEDICS INC · IMMU

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 28, 2018
Accepted (ET)
Mar 12, 2018 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 7, 2018S20,000$17.50D1,774,285D
Common StockF1,F2,F3Feb 28, 2018S17,729$17.09D5,693,252ISee Footnote
Common StockF1,F2,F3Mar 5, 2018S20,000$17.30D5,673,252ISee Footnote
Common StockF1,F2,F3Mar 5, 2018S20,000$17.17D5,653,252ISee Footnote
Common StockF1,F2,F3Mar 7, 2018S20,000$17.60D5,633,252ISee Footnote
Common StockF1,F2,F3Mar 7, 2018S20,000$17.75D5,613,252ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses